Capricor Therapeutics, Inc. financial data

Symbol
CAPR on Nasdaq
Industry
Pharmaceutical Preparations
Location
8840 Wilshire Blvd, 2 Nd Floor, Beverly Hills, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Nile Therapeutics, Inc. (to 11/20/2013), SMI PRODUCTS INC (to 9/19/2007)
Latest financial report
10-K - Q4 2024 - Mar 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 356 % +193%
Debt-to-equity 44.1 % -92.1%
Return On Equity -66.4 % +77.8%
Return On Assets -46.1 % -1.23%
Operating Margin -191 % -99.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45.7M shares +45.5%
Common Stock, Shares, Outstanding 45.6M shares +46.3%
Entity Public Float 140M USD +17%
Common Stock, Value, Issued 45.6K USD +46.3%
Weighted Average Number of Shares Outstanding, Basic 35.2M shares +31.5%
Weighted Average Number of Shares Outstanding, Diluted 35.2M shares +31.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 22.3M USD -11.5%
Research and Development Expense 50M USD +37.1%
General and Administrative Expense 14.9M USD +16.1%
Operating Income (Loss) -42.6M USD -76.8%
Nonoperating Income (Expense) 2.1M USD +17.2%
Net Income (Loss) Attributable to Parent -40.5M USD -81.6%
Earnings Per Share, Basic -1.15 USD/shares -38.6%
Earnings Per Share, Diluted -1.15 USD/shares -38.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 11.3M USD -23.2%
Marketable Securities, Current 140M USD +466%
Cash, Cash Equivalents, and Short-term Investments 152M USD +284%
Assets, Current 163M USD +221%
Property, Plant and Equipment, Net 5.56M USD +0.02%
Operating Lease, Right-of-Use Asset 1.31M USD -36%
Assets 170M USD +190%
Contract with Customer, Liability, Current 12M USD -50.6%
Liabilities, Current 21M USD -32.8%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 616K USD -58.5%
Liabilities 25M USD -30.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.03M USD +335%
Retained Earnings (Accumulated Deficit) -200M USD -25.4%
Stockholders' Equity Attributable to Parent 145M USD +544%
Liabilities and Equity 170M USD +190%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.27M USD -130%
Net Cash Provided by (Used in) Financing Activities 2.29M USD -41.2%
Net Cash Provided by (Used in) Investing Activities -9.5M USD -196%
Common Stock, Shares Authorized 100M shares +100%
Common Stock, Shares, Issued 45.6M shares +46.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11.3M USD -23.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Operating Lease, Liability 1.45M USD -35.1%
Depreciation 1.43M USD +33.3%
Payments to Acquire Property, Plant, and Equipment 609K USD +75%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -39.7M USD -79.1%
Lessee, Operating Lease, Liability, to be Paid 1.55M USD -37.4%
Property, Plant and Equipment, Gross 9.01M USD +16%
Operating Lease, Liability, Current 835K USD +11.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 635K USD -30.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 914K USD +3.11%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 98K USD -58.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 635K USD +15.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Operating Lease, Payments 221K USD +11.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 331K USD +44%
Share-based Payment Arrangement, Expense 9.77M USD +32.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%